Trabectedin/Caelyx vs Cisplatin Hypersensitivity in Relapsed Ovarian Cancer Patients Allergic to Platinum

Clinical trial NCT05512676 · COMPLETED

Trial details

NCT number: NCT05512676
Sponsor: Oslo University Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Ovarian Neoplasm Chemotherapeutic Toxicity Chemotherapy Effect Chemotherapy-induced Neutropenia Chemotherapy-induced Nausea and Vomiting

Start date: 2016-03-07
Primary completion: 2019-05-20
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.